Allay Therapeutics

San Jose, CA · Founded 2016 · Privately Held (backing)

Developer of sustained analgesic products designed to provide post-surgical pain management and recuperation for patients and physicians. Allay Therapeutics is based in San Jose, CA and was founded in 2016. It was valued at $126 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $175 million across 3 recorded rounds; the latest was a $45 million early-stage round in Jan 2025.

PMV mark · valuation
$126.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$174.8M
Last round
Early Stage VC
Jan 2025
What is Allay Therapeutics worth?
$126.0MPrivateMarketView mark · Oct 2026

Valued at $126.0M at its later-stage round, Jun 2025. Nothing has traded since.

Free account
More of Allay Therapeutics with a free account
  • ·The complete investor list: 19 names
  • ·Watch Allay Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Allay Therapeutics funding history

3 rounds
DateRoundRaisedPost-money
Jan 2025Early Stage VC$45.0M▮
Sep 2021Later Stage VC$86.9M▮
Apr 2020Early Stage VC$15.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Allay Therapeutics valuation

Allay Therapeutics was valued at $126 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Allay Therapeutics raised?

Allay Therapeutics has raised $175 million across 3 recorded rounds since 2020. The largest was an $86.9 million later-stage round in Sep 2021; the most recent was a $45 million early-stage round in Jan 2025.

Allay Therapeutics has filed 4 Form Ds with the SEC since 2021, most recently in Feb 2025 ($45 million sold to 18 investors).

How Allay Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Allay Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Allay Therapeutics

What is Allay Therapeutics worth?
Allay Therapeutics is valued at $126.0M as of Oct 2026. Valued at $126.0M at its later-stage round, Jun 2025. Nothing has traded since.
How much has Allay Therapeutics raised?
Allay Therapeutics has raised $174.8M in total funding across 3 recorded rounds.
When did Allay Therapeutics last raise?
Allay Therapeutics last raised in Jan 2025 (Early Stage VC), raising $45.0M.